Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Post-Transplant Complications

Femoral head necrosis in three patients with relapsed ovarian cancer receiving high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation

Summary:

We report three patients with relapsed ovarian cancer who developed femoral head necrosis requiring endoprosthetic hip surgery 16–35 months after high-dose chemotherapy (HDC) with treosulfan (47 and 56 g/m2 body-surface area (BSA)) given as 3–25 h infusions and followed by autologous peripheral blood stem cell (PBSC) transplantation. One woman received two courses of single agent treosulfan while the other two patients received one course of high-dose treosulfan either preceded or followed by high-dose carboplatin, etoposide and cyclophosphamide. A total of 30 women with ovarian cancer were treated with HDC at our unit and 21 of them received treosulfan-containing regimens. Femoral head necrosis was not observed in patients either receiving conditioning regimens without treosulfan (n=9) or when the total treosulfan dose was given over 3 consecutive days (n=3) or in patients with a diagnosis other than ovarian cancer and treated with high-dose treosulfan (n=10). We conclude that women with relapsed ovarian cancer receiving HDC with excessive single-dose treosulfan might be at an increased risk of developing bone necrosis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  1. Stern JM, Sullivan KM, Ott SM et al. Bone density loss after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2001; 7: 257–264.

    Article  CAS  Google Scholar 

  2. Ebeling PR, Thomas DM, Erbas B et al. Mechanism of bone loss following allogeneic and autologous hematopoietic stem cell transplantation. J Bone Miner Res 1999; 14: 342–350.

    Article  CAS  Google Scholar 

  3. Weilbacher KN . Mechanisms of osteoporosis after hematopoietic cell transplantation. Biol Blood Marrow Transplant 2000; 6: 165–174.

    Article  Google Scholar 

  4. Schulte C, Beelen DW, Schaefer UW et al. Bone loss in long-term survivors after transplantation of hematopoietic stem cells: a prospective study. Osteoporosis Int 2000; 11: 344–353.

    Article  CAS  Google Scholar 

  5. Lappe JM, Tinley ST . Prevention of osteoporosis in women treated for hereditary breast and ovarian cancer. Cancer 1998; 83: 830–834.

    Article  CAS  Google Scholar 

  6. Gogas H, Fennelly D . Avascular necrosis following extensive chemotherapy and dexamethasone treatment in a patient with advanced ovarian cancer: case report and review of the literature. Gynecol Oncol 1996; 63: 379–381.

    Article  CAS  Google Scholar 

  7. Scheulen ME, Hilger RA, Oberhoff C et al. Clinical phase I dose escalation and pharmacokinetic study of high-dose chemotherapy with treosulfan and autologous peripheral blood stem cell transplantation in patients with advanced malignancies. Clin Cancer Res 2000; 6: 4209–4216.

    CAS  PubMed  Google Scholar 

  8. Wagner HM, Baumgart J, Andreesen R et al. Dose-escalation of treosulfan in a high-dose-protocol: a classical alkylating agent new in high-dose combination chemotherapy. Proc ASCO 2000; 19: 54a (Abstr. 208).

    Google Scholar 

  9. Baynes RD, Dansey RD, Klein JL et al. A phase I trial of escalating treosulfan in combination with high-dose melphalan and dacarbazine (TMD) with peripheral blood progenitor cell transplant (PBPCT) in recurrent metastatic ovarian and breast cancer. Bone Marrow Transplant 2000; 26 (Suppl. 1) 33 (Abstr. P36).

    Google Scholar 

Download references

Acknowledgements

We thank Dr C Poettgen, University of Essen Medical School, West German Cancer Center, Department of Radiotherapy for critical review of the radiation chart of patient 2, V.B.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bojko, P., Hilger, R., Ruehm, S. et al. Femoral head necrosis in three patients with relapsed ovarian cancer receiving high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 31, 487–491 (2003). https://doi.org/10.1038/sj.bmt.1703886

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1703886

Keywords

Search

Quick links